Login / Signup

Quality of life in patients with locally advanced head and neck squamous cell carcinoma undergoing concurrent chemoradiation with once-a-week versus once-every-3-weeks cisplatin.

Nandini Sharrel MenonVanita NoronhaVijay Maruti PatilAmit JoshiAtanu BhattacharjeeDevanshi KalraSarbani Ghosh LaskarVijayalakshmi MathrudevKavita NawaleArati S BhelekarKumar Prabhash
Published in: Cancer medicine (2022)
The use of once-every-3-weeks cisplatin did not adversely impact QoL as compared to once-a-week cisplatin in combination with radiotherapy in LAHNSCC.
Keyphrases
  • locally advanced
  • rectal cancer
  • neoadjuvant chemotherapy
  • squamous cell carcinoma
  • radiation therapy
  • phase ii study
  • gestational age
  • early stage
  • clinical trial
  • placebo controlled
  • study protocol
  • double blind